Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo

Brown, D.; Henzl, M.R.; LePage, M.E.; Tsao, L.L.; Izu, A.E.; Walker, K.A.; Adamson, G.D.; Droegmuller, W.

Journal of Reproductive Medicine 31(11): 1045-1048

1986


ISSN/ISBN: 0024-7758
PMID: 3543342
Document Number: 361
A double-blind, parallel study was conducted comparing a new imidazole derivative, butoconazole nitrate, with placebo and miconazole nitrate for the treatment of vulvovaginal candidiasis. Patients were randomly assigned to six treatment regimens. Butoconazole was found to be an effective antifungal agent in both the six- and three-day treatment schedules. The incidence of local side effects from both tested imidazoles was low.

Document emailed within 1 workday
Secure & encrypted payments

Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo